Cancer
Researchers at Guangzhou University of Chinese Medicine have made a significant discovery in the field of cancer immunotherapy. A new customized immunomodulator, developed by the team, has been shown to comprehensively reinforce the anti-tumor immunological cascade. This breakthrough has the potential to enhance the efficacy of immunotherapy for cold tumors,
Cancer
Recent research at the First Hospital of Hunan University of Chinese Medicine has shed new light on the potential of metal nanoparticles in cancer diagnosis and treatment. The study, published in the journal Drug Delivery, revealed that metal nanoparticles (MNPs) have unique physicochemical properties that enable precise drug delivery and
Cancer
Researchers at Amity University Uttar Pradesh have highlighted the critical role of membrane transporters in cancer, noting that their expression is frequently reprogrammed to support enhanced growth, survival, and therapy resistance. These transporters, regulated by the tumor suppressor p53, facilitate the uptake and efflux of nutrients, ions, and drugs, making
Cancer
Researchers at Sichuan Cancer Hospital have developed covalent organic frameworks (COFs) that can be tailored for use in cancer treatment and drug delivery. COFs are crystalline and porous materials formed from organic molecules that can have their mechanical properties adjusted to suit various applications. This review summarizes the strategies for
Cancer
Research from the SRM Institute of Science and Technology has highlighted the potential of epigenetic therapies in cancer treatment. According to the study, epigenetic changes, such as DNA methylation and histone modifications, play a key role in cancer development and progression. These changes can be reversed, making them attractive targets
Cancer
Researchers from the Netherlands Cancer Institute have developed an inducible CRISPR-Cas9 screening platform that allows for precise temporal control over gene editing in non-proliferative states. This breakthrough has been published in Nature Protocols, offering a detailed protocol for researchers to follow. The platform has the potential to be applied across
Cancer
Research from Chongqing University Cancer Hospital in China has uncovered a crucial link between HIV reservoirs and the development of lymphoma in people living with HIV (PLWH). Despite advancements in antiretroviral therapy, PLWH remain at high risk of lymphoma, with HIV reservoirs playing a significant role in lymphomagenesis. The study&
Alzheimer's disease
A recent study published in Frontiers in Aging Neuroscience has highlighted the growing global health crisis of Alzheimer's disease and other dementias (ADOD), driven by the rapid aging of the population. According to the research, ADOD incidence, prevalence, and mortality increased significantly between 1990 and 2021, with high
Cancer
New research at the University of Kentucky has made significant breakthroughs in the treatment of endometrial cancer, a type of cancer that affects the lining of the uterus. According to the study, researchers have developed a new drug delivery system (DDS) that can encapsulate a chemotherapy drug called paclitaxel, allowing
Cancer
A retrospective cohort study conducted at the Peter MacCallum Cancer Centre in Melbourne, Australia, aimed to evaluate the incidence, risk factors, and clinical outcomes of multiple viral infections in the first year following allogeneic hematopoietic cell transplantation (alloHCT). The study found that among 430 alloHCT recipients, 744 viral infections were
Cancer
Researchers at Fudan University in Shanghai, China have identified a key mechanism by which endometrial cancer cells evade the immune system and resist immunotherapy. The study, published in the Journal for ImmunoTherapy of Cancer, found that the enzyme O-GlcNAc transferase (OGT) plays a critical role in promoting immune evasion and
Cancer
A new study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, suggests that exemestane, an aromatase inhibitor, may be effective in preventing endometrial cancer. The multi-center, single-arm pilot study enrolled 40 postmenopausal women with endometrial intraepithelial neoplasia (EIN) or low-grade endometrial cancer, who underwent
